Genotypes | CC (%) | CT (%) | TT (%) | No. Of Alleles C/T |
---|---|---|---|---|
Patients (n = 91) | 38 (41.8%) | 47 (51.6%) | 06 (6.6%) | 123/59 (67.6/32.4) |
Controls (n = 200) | 32 (16%) | 110 (55%) | 58 (29%) | 174/226 (43.5/56.5) |
OR at 95% CI | 3.76 (2.144–6.608) | 0.874 (0.532–1.436) | 0.173 (0.071–0.418) | 2.71 (1.874–3.913) |
RE (n = 30) | 12 (40%) | 14 (46.7%) | 4 (13.3%) | 36/22 (62.1/37.9) |
SGF (n = 61) | 26 (42.6%) | 33 (54.1%) | 2 (3.3%) | 85/37 (69.7/30.3) |
P – value and OR at 95% CI (RE vs SGF) | 0.811; OR = 0.89 (0.369–2.185) | 0.505; OR = 0.74 (0.309–1.784) | 0.069; OR = 4.54 (0.781–26.36) | 0.309; OR = 0.71 (0.369–1.373) |
Steroid responsive RE (n = 24) | 9 (37.5%) | 11 (45.83%) | 4 (16.66%) | 29/19 (60.4/39.6) |
Steroid Resistant RE (n = 6) | 3 (50%) | 3 (50%) | 0 | 9/3 (75/25) |